Neimeth International Pharmaceuticals Plc plans to grow its turnover by more than 127.7 per cent in the 2024 financial year compared to what it made in 2023. The company plans to generate
Transactions on the Nigeria Stock Exchange (NSE) reversed the previous session’s gains to close on a downturn yesterday, with market capitalisation depreciating by N8 billion.